Has Daniel Laster, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,152 in general payments to Daniel Laster, MD across 22 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Daniel Laster, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Daniel Laster, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Daniel Laster, MD

Orthopaedic Surgery · Pasadena, CANPI 1457353062

Payments from drug & device makers

$3,152in general payments, 2019–2025

Across 22 payments — averaging $143.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Smith+Nephew$3K
Zimmer Biomet$258
Pacira Therapeutics, Inc.$114
Globus Medical$96
Stryker$68
AbbVie$26
plus $18 from 1 others

What the payments were for

Travel & lodging$1,95962%
Food & beverage$1,19338%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Smith+Nephew	11	$2,572
Zimmer Biomet	3	$258
Pacira Therapeutics, Inc.	1	$114
Globus Medical	3	$96
Stryker	2	$68
AbbVie	1	$26
Nevro Corp.	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,152 in reported general payments places this provider in the 50th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California →

Medicare billing

Part B allowed, 2024

$249,942

Medicare patients

496

Services billed

11,147

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	284	$2,561
Celecoxib	118	$2,493
Diclofenac Sodium	78	$753
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	60	$604
Ibuprofen	17	$244
Gabapentin	35	$172
Cephalexin	33	$93
Tramadol Hcl	37	$89
Meloxicam	59	$77

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Pasadena

John ItamuraPasadena$628K
Bradford HackArcadia$18.3M
Robert GorabOrange$14.5M
Kelly VinceLos Angeles$9.6M
Stephen HowellSacramento$9.4M
Thomas CoonRed Bluff$9.2M
Peter NewtonSan Diego$7M
Nirav AminPlacentia$5.8M
Tom NorrisSan Francisco$5.3M
Jay LiebermanLos Angeles$4.8M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →